skip to main content

Our team advises U.S. and non-U.S. clients across industries on their most sensitive U.S. economic sanctions and Bank Secrecy Act/anti-money laundering (BSA/AML) issues. With our preeminent regulatory defense and white collar experience, we are uniquely positioned to assist clients in responding to regulator inquiries, examinations and subpoenas; conducting internal investigations; and handling matters that develop into multi-agency civil and criminal investigations. Our practice also encompasses regulatory advice, compliance counseling and transactional due diligence. 

Roberto Gonzalez to Discuss Strategies for Establishing Effective Sanctions Programs at Pharmaceutical Compliance Event

Economic Sanctions & AML Co-Chair Roberto Gonzalez will participate in a panel, “Sanctions – Compliance Monitoring Approaches and Tools,” as part of the 24th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress. The panel will discuss regulator expectations for an effective sanctions compliance program, as well as the methodologies, tools and resources used to effectively and efficiently monitor and respond to changes in risk. The Congress, which is hosted in partnership with The Pharmaceutical Compliance Forum and Global Health Care, LLC, brings together experts from across the pharma and device compliance industry to share ideas to enable access to better care and outcomes for patients.

The panel will take place both virtually and in person in National Harbor, Maryland on October 26 at 7:10 a.m. ET.

» register here

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy